Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 114.85
-5.39 (-4.48%)
Apr 21, 2026, 3:00 PM CST
Beijing Hotgen Biotech Revenue
In the year 2025, Beijing Hotgen Biotech had annual revenue of 407.69M CNY, down -20.20%. Beijing Hotgen Biotech had revenue of 97.98M in the quarter ending December 31, 2025, a decrease of -21.45%.
Revenue
407.69M
Revenue Growth
-20.20%
P/S Ratio
26.20
Revenue / Employee
n/a
Employees
850
Market Cap
10.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 407.69M | -103.21M | -20.20% |
| Dec 31, 2024 | 510.90M | -36.94M | -6.74% |
| Dec 31, 2023 | 547.84M | -3.01B | -84.60% |
| Dec 31, 2022 | 3.56B | -1.81B | -33.76% |
| Dec 31, 2021 | 5.37B | 4.86B | 945.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition